Pierre... And to think, we also have "world-wide patent rights" for PBT2 facilitating antibiotic efficacy against bacterial infections. I guess we're all sitting in the catbird seat except for the long wait for something tangible to happen in our lifetime.
Ann: New US patent targeting major neurodegenerative diseases, page-7
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $11.46K | 2.327M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 89724945 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27630177 | 21 |
View Market Depth
| Last trade - 15.30pm 17/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
